Analyze Diet
Veterinary immunology and immunopathology2007; 121(1-2); 144-149; doi: 10.1016/j.vetimm.2007.09.002

Characterization of equine P-selectin glycoprotein ligand-1 by using a specific monoclonal antibody.

Abstract: P-selectin glycoprotein ligand (PSGL-1) is a widely distributed adhesion molecule that plays a critical role in regulating lymphocyte homing and leukocyte trafficking during inflammation. The lack of specific reagents for equine PSGL-1 (ePSGL-1) has prevented mechanistic studies regarding its function and regulation in the horse. We synthesized a ePSGL-1 peptide to generate a monoclonal antibody (mAb), ePL1. Using flow cytometry and Western blot, we showed that ePL1 binds specifically to ePSGL-1 in transfected mammalian cells. We also demonstrated that ePL1 binds to equine leukocytes and recognized a protein with molecular weight 165 and 280kDa under reducing and non-reducing condition, respectively, likely corresponding to ePSGL-1. Seventy percent of equine monocytes bound by both ePL1 and HECA-452, an antibody defining sLex-like carbohydrate epitope. Both ePL1 and HECA-452 recognized ePSGL-1 protein precipitated by equine P-selectin-IgG chimera. Neuraminidase treatment increased ePL1 binding and the molecular weight of ePSGL-1, O-sialoglycoprotein endopeptidase digestion and tyrosine mutation abolished ePL1 staining and recognition. The ePL1 specific binding epitope appears to be the polypeptide backbone of ePSGL-1 in the presence of tyrosine but the process is independent of sialylation modification. In conclusion, we provide evidence that this antibody can be used for cell surface staining and immune-blot analyses.
Publication Date: 2007-09-16 PubMed ID: 17980439DOI: 10.1016/j.vetimm.2007.09.002Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study is aimed at characterizing a specific molecule, P-selectin glycoprotein ligand-1 (PSGL-1), in horses using a synthesized monoclonal antibody. This immune molecule is important for immune cell functioning and inflammation.

Introduction

  • PSGL-1 is an adhesion molecule that is significant for leukocyte trafficking and lymphocyte homing during inflammation.
  • Understanding its function and regulation in horses has been hampered due to the lack of specific reagents for equine PSGL-1, also known as ePSGL-1.

Methods

  • A monoclonal antibody, ePL1, was created for the study by synthesizing an ePSGL-1 peptide.
  • Flow cytometry and Western blot techniques were used to demonstrate that ePL1 has a specific binding affinity for ePSGL-1 in cells transfected from mammals.
  • Further investigation proved that ePL1 binds to equine leukocytes and recognizes a protein that has a molecular weight of 165 and 280kDa under varying conditions.

Findings

  • Testing found that about seventy percent of horse monocytes were bound by both ePL1 and HECA-452, which is another antibody that defines similar carbohydrate epitopes, suggesting the presence of ePSGL-1.
  • It was found that treatment with neuraminidase increased the binding of ePL1 and the molecular weight of ePSGL-1.
  • Digestion with o-sialoglycoprotein endopeptidase and tyrosine mutation prevented ePL1 from staining and recognizing the molecule.

Conclusions

  • The unique binding epitope for ePL1 appears to be the polypeptide backbone of ePSGL-1, with tyrosine present but the process doesn’t depend on sialylation modification.
  • This antibody can be beneficial for conducting further cell surface staining and immune-blot analyses.

By understanding the binding nature of ePL1 and its impact on the ePSGL-1 immune response, a new avenue to better interpret the equine immune system opens up. This could shed light on potential therapeutic strategies for immune-related diseases in horses.

Cite This Article

APA
Xu J, Cai J, Peek SF, Suresh M, Darien BJ. (2007). Characterization of equine P-selectin glycoprotein ligand-1 by using a specific monoclonal antibody. Vet Immunol Immunopathol, 121(1-2), 144-149. https://doi.org/10.1016/j.vetimm.2007.09.002

Publication

ISSN: 0165-2427
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 121
Issue: 1-2
Pages: 144-149

Researcher Affiliations

Xu, Jin
  • Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706-1102, USA.
Cai, Jun
    Peek, Simon F
      Suresh, M
        Darien, Benjamin J

          MeSH Terms

          • Animals
          • Antibodies, Monoclonal / immunology
          • Blotting, Western / veterinary
          • CHO Cells
          • Cricetinae
          • Cricetulus
          • Epitopes / immunology
          • Flow Cytometry / veterinary
          • Horses / immunology
          • Leukocytes / immunology
          • Membrane Glycoproteins / immunology
          • Transfection / veterinary

          Citations

          This article has been cited 0 times.